Navigation Links
Hospira Reports Third-Quarter 2012 Results
Date:11/7/2012

"FDA") warning letters and charges related to certain device related remediation activities.(D)

Capacity expansion related charges reported in Cost of products sold include start-up charges related to manufacturing capacity expansion in India.(E)

Other Restructuring Charges: $(1.9) million reported in Restructuring, impairment, and (gain) on disposition of assets, net, for a gain on disposition of a non-strategic product line.Three months ended September 30, 2011 Reconciliation of GAAP to Non-GAAP Financial Measures:Gross Profit (1) (Loss) Income

From Operations Net (Loss)

Income (2)Diluted EPSGAAP financial measures$
303.9$
(85.2)$
(88.9)$
(0.54)Specified item:   Amortization of certain intangible assets (A)19.219.213.00.08   Impairment of certain assets (B) -15.210.40.06   Certain quality and product related charges (C)36.736.722.90.14   Capacity expansion related charges (D)1.51.51.00.01   Goodwill impairment (E)-155.0151.30.92   Diluted shares impact(0.01)Adjusted financial measures (3)$
361.3$
42.4$
9.7$
.66GAAP results for the three months ended September 30, 2011 include:(A)

Amortization of certain intangible assets: $19.2 million reported in Cost of products sold resulting from acquisitions including Mayne Pharma, Javelin Pharma and a generic injectable business by Hospira India.(B)

Impairment of certain assets: $15.2 million reported in Restructuring, impairment and (gain) on disposition of assets, net, related to impairments of certain intangible assets.(C)

Certain quality and product related charges reported in Cost of products sold primarily include third party oversight and consulting costs, extended production
'/>"/>

SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Reports First-Quarter 2012 Results
3. Hospira to Present at Upcoming Investor Conferences
4. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
5. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
6. Hospira to Host Conference Call for Second-quarter 2012 Results
7. Hospira Expands Board of Directors With Election of Dennis M. Fenton
8. Hospira Reports Second-Quarter 2012 Results
9. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)...  Semler Scientific, Inc. (Nasdaq: SMLR ... that develops patented products that assist healthcare providers ... reported financial results for the third quarter and ... "In the third quarter of 2014, Semler,s ... chief executive officer of Semler.  "We moved forward ...
(Date:10/31/2014)... 31, 2014 Mast Therapeutics, Inc. (NYSE MKT: ... for the quarter ended September 30, 2014. ... said:  "The third quarter was productive for Mast. Consistent with ... MST-188 for sickle cell disease is on track to ... have opened 50 study sites in the U.S. and ...
(Date:10/31/2014)... 2014  Lycera Corp., a biopharmaceutical company developing ... and cancer, today announced that data on the ... candidates will be presented at the annual meeting ... being held November 6-9, 2014 at the Gaylord ...  The poster, entitled " Novel synthetic RORgamma agonist ...
Breaking Medicine Technology:Semler Reports Third Quarter 2014 Financial Results 2Semler Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 4Mast Therapeutics Reports Third Quarter 2014 Financial Results 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 6Mast Therapeutics Reports Third Quarter 2014 Financial Results 7Mast Therapeutics Reports Third Quarter 2014 Financial Results 8Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2
... , BOTHELL, Wash., Nov. 30 SCOLR Pharma, Inc. ... 25, 2009, the NYSE Amex LLC (the "Exchange") notified the ... with its previously disclosed listing deficiency under Section 1003(a)(iv) of ... that the Company sustained losses which were so substantial in ...
... , ... new market research report is available in its catalogue: ... , http://www.reportlinker.com/p0164331/Operating-Tables---A-World-Market-Review.html , Operating tables are ... possible position for the surgeon to conduct the surgical ...
Cached Medicine Technology:SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Operating Tables - A World Market Review 2Reportlinker Adds Operating Tables - A World Market Review 3Reportlinker Adds Operating Tables - A World Market Review 4Reportlinker Adds Operating Tables - A World Market Review 5
(Date:10/31/2014)... Oct. 30, 2014 (HealthDay News) -- Each year, people ... hours caring for older relatives and friends, which costs ... Corp. study put a price tag on the time ... help older people who need assistance in daily activities. ... informal care has generated interest in workplace flexibility policies. ...
(Date:10/31/2014)... A new report by Milken Institute School of ... Washington University examines the challenge of maintaining enriched ... in Covered California and who are also eligible ... Program (CPSP). The CPSP, whose roots are in ... developed for low-income pregnant women, makes enriched maternity ...
(Date:10/30/2014)... Albert Einstein College of Medicine of ... will present their latest aging research at the ... Meeting. Topics include the identification of a genotype ... impairment and the cellular biology of aging. GSA ... Washington, D.C., "Einstein-Montefiore has distinguished itself in a ...
(Date:10/30/2014)... of data from an institutional patient registry on ... control, 79 percent of tumors, for medically inoperable, ... from 2003 to 2012, according to research presented ... Thoracic Oncology. The Symposium is sponsored by the ... Society for Radiation Oncology (ASTRO), the International Association ...
(Date:10/30/2014)... research group at the DFG Research Center for Regenerative ... Dresden (CRTD) demonstrated for the first time the in ... three dimensions from mouse embryonic stem cells. Correct spatial ... the dorsal/ventral axis was observed., This study has been ... Cell Reports " on 30.10.2014 ., For many years ...
Breaking Medicine News(10 mins):Health News:'Informal Care' for Older Americans Tops $500B Annually, Study Finds 2Health News:Report examines health care challenges for pregnant women enrolled in covered California 2Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 2Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 3Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 4Health News:Sustained local control for medically inoperable, early stage lung cancer patients 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 3Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2
... CRANSTON, R.I., Nov. 27 A new, ... manufacturers (OEMs) on choosing the,right electronics manufacturing ... available free to download at, http://www.federalelec.com/medicalpaper ., ... need for consistent quality and,conformance to product ...
... 27, 2007, 4:00 p.m. E.S.T. - Positron emission tomography ... need for more accurate staging of lung cancer and ... published online today in Journal of National Cancer Institute. ... Cancer Disease Site Group of Cancer Care Ontarios Program ...
... Nov. 27 A new study that shows young ... for men has leveled off offers,strong evidence that preventive ... war on cardiovascular disease, said Christopher T. Fey, the,chairman ... released study published in Journal of the American College ...
... therapies, experts say , , TUESDAY, Nov. 27 (HealthDay News) ... doctors predict which postmenopausal women are likely to sustain ... algorithm includes 11 different factors -- such as age ... of different ethnic backgrounds. , "Knowing the 5-year ...
... Risk Elevated in Male BRCA Mutation Carriers , Men with ... of breast cancer than the general population. , Male breast cancer ... the U.S., and it is most common in men with a ... who carry mutations in the BRCA2 gene have a greater risk ...
... R.I. [Brown University] Heavy smoking and drinking are ... human papillomavirus type 16 (HPV16), a common strain of ... for head and neck cancer, which affects about 500,000 ... however, shows that alcohol and tobacco use doesnt further ...
Cached Medicine News:Health News:White Paper Details How to Choose the Right EMS Provider for Medical Products Outsourcing 2Health News:PET imaging significantly enhances standard imaging in lung cancer staging 2Health News:US Preventive Medicine(R) Says Study on Heart Disease-related Deaths Demonstrates Need for Preventive Medical Care 2Health News:US Preventive Medicine(R) Says Study on Heart Disease-related Deaths Demonstrates Need for Preventive Medical Care 3Health News:Criteria Predict Women's 5-Year Risk for Fracture 2Health News:Other Highlights in the Nov. 27 JNCI 2Health News:Other Highlights in the Nov. 27 JNCI 3Health News:Other Highlights in the Nov. 27 JNCI 4Health News:Drinking and smoking don't boost HPV-related cancer risk 2
A flexible hematology platform:, 32 parameters, Automatic result validation, Cytology atlas included, CBC and 5+3 DIFF...
... L.E.D. is mounted coaxially on the loupe ... battery pack giving 4 hours continuous use. ... and a charging unit that can hold ... as being a convenient container to keep ...
The PDM utilizes the latest technology for measuring interpupillary distance and left/right pupil-to-nose distance. Lightweight and easy-to-use, the PDM provides accurate and repeatable PD measuremen...
Inquire...
Medicine Products: